Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis

NCT00599274 · clinicaltrials.gov ↗

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Interferon beta-1a
DRUG: Interferon beta-1a

Sponsor

Biogen